iRadimed IRMD EBITDA

EBITDA at other companies

GE HealthCare TechnologiesGEHC

$899M+12.1%

Merit Medical SystemsMMSI

$74.65M+6.2%

ICU MedicalICUI

$88.74M+47.3%

StereotaxisSTXS

-$5.59M-0.5%

InfuSystem HoldingsINFU

$4.84M+23.0%

Lumexa Imaging Holdings, Inc.LMRI

$29.33M-15.2%

FAQ

What is iRadimed's EBITDA?

iRadimed (IRMD) reported EBITDA of $7.69M in Q1 2026.

How has iRadimed's EBITDA changed year-over-year?

iRadimed's EBITDA increased by 36.7% year-over-year, from $5.63M to $7.69M.

What is the long-term trend for iRadimed's EBITDA?

Over 3 years (2021 to 2025), iRadimed's EBITDA has grown at a 34.5% compound annual growth rate (CAGR), from $11.22M to $27.31M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.